Preferred Label : Drug-Eluting stents;

MeSH definition : Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.;

MeSH synonym : drug-eluting stent; stents, drug eluting; stent, drug-eluting; stents, drug-eluting; drug eluting stents; Drug Eluting Stent;

Related MeSH term : Drug-Coated stents; Drug Coated Stents; Drug-Coated Stent; Stent, Drug-Coated; Stents, Drug-Coated; Stents, Drug Coated; Drug Coated Stent;

Details


Main resources

You can consult :

Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.

https://www.has-sante.fr/jcms/p_3417225/fr/nitides
2023
France
health technology assessment
Drug-Eluting stents
Endoprosthesis
sirolimus

---
https://www.has-sante.fr/jcms/p_3264253/fr/titan-optimax
2021
false
false
false
France
titanium
coronary artery disease
treatment outcome
Drug-Eluting stents
coronary artery disease
health technology assessment
Drug-Eluting stents

---
https://www.has-sante.fr/jcms/p_3193726/fr/orsiro-mission
2020
France
health technology assessment
Religious Missions
stents
Drug-Eluting stents

---
https://www.has-sante.fr/jcms/p_3169471/fr/xience-prime-btk
2020
France
health technology assessment
Drug-Eluting stents
stents

---
https://www.has-sante.fr/jcms/p_3193740/fr/orsiro
2020
false
false
false
France
health technology assessment
stents
Drug-Eluting stents

---
https://www.has-sante.fr/portail/jcms/c_2902390/fr/yukon-chrome-pc
2019
false
false
false
France
Drug-Eluting stents
coronary disease
treatment outcome
health technology assessment
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2902384/fr/elunir
2019
false
false
false
France
Drug-Eluting stents
coronary disease
treatment outcome
health technology assessment
ridaforolimus
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2963184/fr/coroflex-isar
2019
false
true
false
France
coronary disease
treatment outcome
health technology assessment
Drug-Eluting stents
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2963205/fr/coroflex-isar-neo
2019
false
true
false
false
France
coronary disease
coronary disease
treatment outcome
health technology assessment
sirolimus
Drug-Eluting stents

---
Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69848a-fra.php
2019
false
false
false
Canada
French
English
equipment and supplies note
Drug-Eluting stents
angioplasty, balloon
paclitaxel
peripheral arterial disease
coated materials, biocompatible
cause of death

---
http://www.sudoc.fr/240885392
2019
France
dissertations, academic
generations
Safety
safety
family characteristics
Meta-Analysis
Drug-Eluting stents
review literature as topic
meta-analysis as topic
Literature
meta-analysis

---
https://www.has-sante.fr/portail/jcms/c_2968543/fr/orsiro
2019
false
false
false
France
coronary disease
treatment outcome
evaluation of the transparency committee
sirolimus
Drug-Eluting stents

---
https://www.has-sante.fr/jcms/p_3101057/fr/combo-plus-stent
2019
France
health technology assessment
extracellular matrix
templates, genetic
pharmacology
monoclonal antibody
Monoclonal antibodies
pharmacologist
stents
sirolimus
Drug-Eluting stents
antibodies, monoclonal
Monoclonal antibodies
antibodies, anti-idiotypic
antigens, CD34
stents

---
https://www.has-sante.fr/jcms/p_3115332/fr/promus-premier-btk-promus-premier-over-the-wire-btk-et-promus-premier-monorail-btk
2019
France
health technology assessment
Everolimus
tea, nos
stents
tea
tetrahydrocortisone
Drug-Eluting stents
everolimus
stents

---
https://www.has-sante.fr/jcms/p_3115341/fr/zilver-ptx
2019
France
health technology assessment
paclitaxel
pneumothorax
Drug-Eluting stents
paclitaxel
stents
stents

---
https://www.ansm.sante.fr/actualites/recommandations-de-traitement-de-larteriopathie-obliterante-des-membres-inferieurs-aomi-a-laide-de-dispositifs-medicaux-au-paclitaxel
2019
false
false
false
France
meta-analysis as topic
mortality, excess
Drug-Eluting stents
angioplasty, balloon
angioplasty, balloon
cardiovascular diseases
continuity of patient care
coated materials, biocompatible
guideline
paclitaxel
Lower limb occlusive arterial disease
arterial occlusive diseases
lower extremity
mortality

---
https://www.has-sante.fr/portail/jcms/c_2896009/fr/yukon-choice-pc
2018
France
health technology assessment
sirolimus
yukon territory
Drug-Eluting stents
stents
pharmacology
pharmacologist
stents

---
https://www.has-sante.fr/portail/jcms/c_2820665/fr/xience-sierra
2018
false
false
false
France
French
health technology assessment
active
Drug-Eluting stents
released
stents
stents

---
http://www.has-sante.fr/portail/jcms/c_2752881/fr/magmaris
2017
false
false
false
France
French
health technology assessment
stents
Drug-Eluting stents
released
active
stents

---
https://www.has-sante.fr/portail/jcms/c_2772238/fr/ultimaster
2017
false
false
false
France
French
health technology assessment
active
Drug-Eluting stents
released
stents
stents

---
http://www.has-sante.fr/portail/jcms/c_2754728/fr/coroflex-isar
2017
false
false
false
France
French
health technology assessment
stents
Drug-Eluting stents
released
active
stents

---
http://www.has-sante.fr/portail/jcms/c_2590004/fr/absorb-gt1
2016
false
false
false
false
France
French
Drug-Eluting stents
coronary disease
blood vessel prosthesis implantation
blood vessel prosthesis
Everolimus

---
http://www.has-sante.fr/portail/jcms/c_2657488/fr/synergy
2016
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
Everolimus
coronary disease

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1065/850
2016
false
false
false
false
Canada
French
drug administration schedule
critical appraisal or critical reading
Drug-Eluting stents
drug therapy, combination
multicenter studies as topic
thrombosis
aspirin
aspirin
Prasugrel Hydrochloride
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
thienopyridine
platelet aggregation inhibitors
Drug-eluting coronary stent placement
hemorrhage
Coronary stent thrombosis
thienopyridine
stroke
myocardial infarction
time
platelet aggregation inhibitors
pyridines
pyridines
Clopidogrel

---
http://www.has-sante.fr/portail/jcms/c_2590001/fr/absorb
http://www.has-sante.fr/portail/jcms/c_2590000/fr/absorb
2016
false
false
false
false
France
French
health technology assessment
immunosuppressive agents
Drug-Eluting stents
coronary artery disease
Everolimus

---
http://www.has-sante.fr/portail/jcms/c_2003841/fr/xience-v
http://www.has-sante.fr/portail/jcms/c_2003840/fr/xience-v
2015
false
false
false
false
France
French
Drug-Eluting stents
blood vessel prosthesis implantation
coronary artery disease
blood vessel prosthesis
sirolimus
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2062589/fr/biomatrix-flex
http://www.has-sante.fr/portail/jcms/c_2062588/fr/biomatrix-flex
2015
false
false
false
false
France
French
Drug-Eluting stents
treatment outcome
coronary artery disease
blood vessel prosthesis
blood vessel prosthesis implantation
sirolimus
immunosuppressive agents
umirolimus
health technology assessment

---
http://www.has-sante.fr/portail/jcms/c_2011476/fr/promus-element-plus
http://www.has-sante.fr/portail/jcms/c_2011475/fr/promus-element-plus
2015
false
false
false
France
French
Drug-Eluting stents
immunosuppressive agents
health technology assessment
coronary artery disease
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2011473/fr/promus-premier
http://www.has-sante.fr/portail/jcms/c_2011472/fr/promus-premier
2015
false
false
false
false
France
French
health technology assessment
coronary artery disease
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
immunosuppressive agents
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013087/fr/resolute-onyx
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
blood vessel prosthesis implantation
blood vessel prosthesis
zotarolimus
sirolimus
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2011109/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_2011108/fr/resolute-integrity
2015
false
false
false
false
France
French
Drug-Eluting stents
health technology assessment
coronary artery disease
blood vessel prosthesis implantation
blood vessel prosthesis
zotarolimus
sirolimus
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013081/fr/xience-alpine
http://www.has-sante.fr/portail/jcms/c_2013080/fr/xience-alpine
2015
false
false
false
false
France
French
immunosuppressive agents
Drug-Eluting stents
health technology assessment
coronary artery disease
blood vessel prosthesis
blood vessel prosthesis implantation
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013096/fr/endeavor-resolute
2015
false
false
false
false
France
French
zotarolimus
sirolimus
immunosuppressive agents
Drug-Eluting stents
blood vessel prosthesis implantation
blood vessel prosthesis
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2013093/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_2013092/fr/resolute-integrity
2015
false
false
false
false
France
French
Drug-Eluting stents
blood vessel prosthesis implantation
blood vessel prosthesis
coronary artery disease
sirolimus
immunosuppressive agents
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2021476/fr/synergy
2015
false
false
false
false
France
French
Drug-Eluting stents
coronary artery disease
immunosuppressive agents
health technology assessment
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2018891/fr/ultimaster
http://www.has-sante.fr/portail/jcms/c_2018890/fr/ultimaster
2015
false
false
false
false
France
French
Drug-Eluting stents
sirolimus
immunosuppressive agents
health technology assessment
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2026097/en/zilver-ptx
http://www.has-sante.fr/portail/jcms/c_2026096/en/zilver-ptx
2015
false
false
false
false
France
French
Drug-Eluting stents
lower extremity
Lower limb occlusive arterial disease
arterial occlusive diseases
paclitaxel
blood vessel prosthesis implantation
blood vessel prosthesis

---
http://www.has-sante.fr/portail/jcms/c_2034379/fr/orsiro
http://www.has-sante.fr/portail/jcms/c_2034378/fr/orsiro
2015
false
false
false
false
France
French
Drug-Eluting stents
sirolimus
health technology assessment
coronary artery disease
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2034376/fr/yukon-choice-pc
http://www.has-sante.fr/portail/jcms/c_2034375/fr/yukon-choice-pc
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
sirolimus
immunosuppressive agents
treatment outcome

---
http://cedit.aphp.fr/stents-coronaires-entierement-resorbables/
2015
false
false
false
France
health technology assessment
Drug-Eluting stents
coronary disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2062737/fr/promus-premier-btk-over-the-wire
http://www.has-sante.fr/portail/jcms/c_2062736/fr/promus-premier-over-the-wire
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
arterial occlusive diseases
lower extremity
immunosuppressive agents
Everolimus

---
http://www.has-sante.fr/portail/jcms/c_2062734/fr/promus-premier-btk-monorail
http://www.has-sante.fr/portail/jcms/c_2062733/fr/promus-premier-monorail-btk
2015
false
false
false
false
France
French
health technology assessment
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
immunosuppressive agents
arterial occlusive diseases
lower extremity
Everolimus

---
http://www.has-sante.fr/portail/jcms/c_2062616/fr/biomatrix
http://www.has-sante.fr/portail/jcms/c_2062615/fr/biomatrix
2015
false
false
false
false
France
French
Drug-Eluting stents
treatment outcome
coronary artery disease
health technology assessment
blood vessel prosthesis
blood vessel prosthesis implantation
umirolimus

---
http://www.has-sante.fr/portail/jcms/c_2062613/fr/biomatrix-neoflex
http://www.has-sante.fr/portail/jcms/c_2062612/fr/biomatrix-neoflex
2015
false
false
false
false
France
French
coronary artery disease
health technology assessment
sirolimus
immunosuppressive agents
Drug-Eluting stents
blood vessel prosthesis
blood vessel prosthesis implantation
umirolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2012834/fr/nobori
http://www.has-sante.fr/portail/jcms/c_2012833/fr/nobori
2015
false
false
false
false
France
French
Drug-Eluting stents
umirolimus
sirolimus
coronary artery disease
blood vessel prosthesis implantation
blood vessel prosthesis
immunosuppressive agents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1726953/fr/orsiro
http://www.has-sante.fr/portail/jcms/c_1726952/fr/orsiro
2014
France
French
Drug-Eluting stents
sirolimus
health technology assessment
coronary artery disease
anti-bacterial agents
ACTIVE CORONARY STENT
antibiotic therapy
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1733330/fr/promus-element-plus
http://www.has-sante.fr/portail/jcms/c_1733329/fr/promus-element-plus
2014
false
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1733327/fr/promus-premier
http://www.has-sante.fr/portail/jcms/c_1733326/fr/promus-premier
2014
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1752091/fr/helistent-titan-2
2014
false
false
false
France
French
Drug-Eluting stents
health technology assessment
titanium
coronary artery disease
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1748776/fr/titan-optimax
http://www.has-sante.fr/portail/jcms/c_1748775/fr/titan-optimax
2014
false
false
false
France
French
Drug-Eluting stents
titanium
coronary artery disease
health technology assessment
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2003864/fr/xience-xpedition
http://www.has-sante.fr/portail/jcms/c_2003863/fr/xience-xpedition
2014
false
false
false
false
France
French
coronary artery disease
sirolimus
Drug-Eluting stents
blood vessel prosthesis implantation
blood vessel prosthesis
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
http://has-sante.fr/portail/jcms/c_1748776/fr/titan-optimax
http://has-sante.fr/portail/jcms/c_1748775/fr/titan-optimax
2014
false
false
false
France
French
Drug-Eluting stents
health technology assessment
titanium
coronary artery disease
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1752088/fr/cre8
http://www.has-sante.fr/portail/jcms/c_1752087/fr/cre8
2014
false
false
false
France
French
health technology assessment
Drug-Eluting stents
coronary artery disease
sirolimus
immunosuppressive agents
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1755993/fr/coroflex-isar
http://www.has-sante.fr/portail/jcms/c_1755992/fr/coroflex-isar
2014
false
false
false
France
French
health technology assessment
Drug-Eluting stents
sirolimus
blood vessel prosthesis implantation
blood vessel prosthesis
coronary artery disease
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1770297/fr/ultimaster
http://www.has-sante.fr/portail/jcms/c_1770296/fr/ultimaster
2014
false
false
false
false
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
immunosuppressive agents
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_2003867/fr/xience-prime
http://www.has-sante.fr/portail/jcms/c_2003866/fr/xience-prime
2014
false
false
false
false
France
French
Drug-Eluting stents
coronary artery disease
blood vessel prosthesis
blood vessel prosthesis implantation
health technology assessment
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://has-sante.fr/portail/jcms/c_1752091/fr/helistent-titan-2
http://has-sante.fr/portail/jcms/c_1752090/fr/helistent-titan-2
2014
false
false
false
France
French
Drug-Eluting stents
health technology assessment
titanium
coronary artery disease
CORONARY STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1350943/gamme-xience-prime-endoprothese-coronaire-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_1350941/xience-prime-18-decembre-2012-4260-avis
http://www.has-sante.fr/portail/jcms/c_1350942/xience-prime-18-decembre-2012-4364-avis
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
https://www.revmed.ch/RMS/2013/RMS-381/Stents-coronariens-bioresorbables-une-revolution
2013
Switzerland
French
Drug-Eluting stents
journal article
coronary restenosis
Drug-Eluting stents
coronary disease
coronary thrombosis
CORONARY STENT, OTHER

---
http://www.has-sante.fr/portail/jcms/c_1545470/fr/nobori-systeme-d-endoprothese-coronaire
http://www.has-sante.fr/portail/jcms/c_1545469/fr/nobori-23-avril-2013-4396-avis
2013
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
umirolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1598316/fr/promus-premier-systeme-de-stent-coronaire-a-elution-d-everolimus
http://www.has-sante.fr/portail/jcms/c_1598315/fr/promus-premier-14-mai-2013-4440-avis
2013
false
France
French
CORONARY STENT, OTHER
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1622853/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_1622852/fr/resolute-integrity
2013
France
French
CORONARY STENT, OTHER
health technology assessment
Drug-Eluting stents
sirolimus
zotarolimus
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1622853/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_1622852/fr/resolute-integrity
2013
France
French
CORONARY STENT, OTHER
health technology assessment
coronary artery disease
Drug-Eluting stents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1625028/fr/xience-prime-btk
http://www.has-sante.fr/portail/jcms/c_1625027/fr/xience-prime-btk
2013
false
France
French
PERIPHERAL STENT, OTHER
Everolimus
Drug-Eluting stents
health technology assessment
arterial occlusive diseases
lower extremity
immunosuppressive agents
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1647377/fr/gamme-xience-xpedition
http://www.has-sante.fr/portail/jcms/c_1647376/fr/gamme-xience-xpedition
2013
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1711197/fr/promus-element-plus-btk-monorail-btk
http://www.has-sante.fr/portail/jcms/c_1715145/fr/promus-element-plus-btk-monorail
2013
France
French
Drug-Eluting stents
health technology assessment
lower extremity
arterial occlusive diseases
PERIPHERAL STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1711208/fr/promus-element-plus-btk-over-the-wire
http://www.has-sante.fr/portail/jcms/c_1715141/fr/promus-element-plus-btk-over-the-wire
2013
France
French
Drug-Eluting stents
health technology assessment
lower extremity
arterial occlusive diseases
PERIPHERAL STENT, OTHER
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1716229/fr/xience-prime
http://www.has-sante.fr/portail/jcms/c_1716228/fr/xience-prime
2013
false
France
French
Drug-Eluting stents
health technology assessment
coronary artery disease
immunosuppressive agents
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1716226/fr/xience-xpedition
http://www.has-sante.fr/portail/jcms/c_1716225/fr/xience-xpedition
2013
false
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
immunosuppressive agents
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1716211/fr/xience-v
http://www.has-sante.fr/portail/jcms/c_1716210/fr/xience-v
2013
false
France
French
Drug-Eluting stents
immunosuppressive agents
coronary artery disease
health technology assessment
ACTIVE CORONARY STENT
Everolimus
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1715363/fr/biomatrix
http://www.has-sante.fr/portail/jcms/c_1716081/fr/biomatrix
2013
France
French
Drug-Eluting stents
coronary artery disease
health technology assessment
sirolimus
umirolimus
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1715362/fr/biomatrix-flex
http://www.has-sante.fr/portail/jcms/c_1716084/fr/biomatrix-flex
2013
France
French
Drug-Eluting stents
coronary artery disease
sirolimus
umirolimus
health technology assessment
ACTIVE CORONARY STENT
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1536376/fr/synergy
http://www.has-sante.fr/portail/jcms/c_1536384/fr/synergy
2013
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary disease

---
http://www.has-sante.fr/portail/jcms/c_1216621/nobori-21-fevrier-2012-4217-avis
http://www.has-sante.fr/portail/jcms/c_1231920/nobori-21-fevrier-2012-4217-avis
2012
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
sirolimus
umirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1237054/cre8-15-mai-2012-4218-avis
http://www.has-sante.fr/portail/jcms/c_1250477/cre-8-15-mai-2012-4218-avis
2012
France
French
health technology assessment
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_868765/fiche-de-bon-usage-angioplastie-coronarienne-interet-et-limites-des-stents-actifs
https://www.has-sante.fr/jcms/r_1437970
2012
true
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
blood vessel prosthesis
coronary disease
angioplasty, balloon, coronary
guidelines for medical devices use

---
http://www.has-sante.fr/portail/jcms/c_1350944/gamme-xience-v-endoprothese-coronaire-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_1350947/xience-v-18-decembre-2012-4244-avis
http://www.has-sante.fr/portail/jcms/c_1350948/xience-v-18-decembre-2012-4263-avis
2012
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1351909/resolute-integrity
2012
France
French
CORONARY STENT, OTHER
coronary artery disease
Drug-Eluting stents
zotarolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1350928/gamme-xience-xpedition-endoprothese-coronaire-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_1351201/xience-xpedition-18-decembre-2012-4410-avis
http://www.has-sante.fr/portail/jcms/c_1351207/xience-xpedition-18-decembre-2012-4354-avis
2012
false
France
French
ACTIVE CORONARY STENT
Everolimus
coronary artery disease
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1045976/xience-prime-22-mars-2011-3399-synthese-d-avis
2011
false
France
French
ACTIVE CORONARY STENT
guidelines for medical devices use
health technology assessment
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1064064/promus-element-14-juin-2011-3836-avis
http://www.has-sante.fr/portail/jcms/c_1064065/promus-element-14-juin-2011-3836-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
health technology assessment
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1058487/promus-14-juin-2011-3832-avis
http://www.has-sante.fr/portail/jcms/c_1064062/promus-14-juin-2011-3832-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
health technology assessment
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1067927/endeavor-resolute-12-juillet-2011-3834-avis
http://www.has-sante.fr/portail/jcms/c_1079788/endeavor-resolute-12-juillet-2011-3834-avis
2011
France
French
ACTIVE CORONARY STENT
diagnostic uses of chemicals
Drug-Eluting stents
zotarolimus
sirolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1068127/resolute-integrity-12-juillet-2011-3835-avis
http://www.has-sante.fr/portail/jcms/c_1079790/resolute-integrity-12-juillet-2011-3835-avis
2011
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
sirolimus
zotarolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1092597/promus-element-plus-13-septembre-2011-3932-avis
http://www.has-sante.fr/portail/jcms/c_1098120/promus-element-plus-13-septembre-2011-3932-avis
2011
false
France
French
health technology assessment
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1068588/xience-v-27-septembre-2011-3857-avis
http://www.has-sante.fr/portail/jcms/c_1100488/xience-v-27-septembre-2011-3857-avis
2011
false
France
French
health technology assessment
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1068582/xience-prime-27-septembre-2011-3859-avis
http://www.has-sante.fr/portail/jcms/c_1100486/xience-prime-27-septembre-2011-3859-avis
2011
false
France
French
health technology assessment
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1122211/taxus-element-29-novembre-2011-3996-avis
http://www.has-sante.fr/portail/jcms/c_1146959/taxus-element-29-novembre-2011-3996-avis
2011
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
paclitaxel
coronary stenosis

---
http://www.has-sante.fr/portail/jcms/c_1197007/endeavor-resolute-3834-et-resolute-integrity-3835-12-juillet-2011-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1216278/endeavor-resolute-3834-resolute-integrity-3835-12-juillet-2011-synthese-d-avis
2011
France
French
ACTIVE CORONARY STENT
sirolimus
Drug-Eluting stents
zotarolimus
sirolimus
coronary artery disease
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1045967/promus-et-promus-element-12-octobre-2010-3009-synthese-d-avis
2011
false
France
French
ACTIVE CORONARY STENT
health technology assessment
guidelines for medical devices use
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1237197/xience-v-3857-et-xience-prime-3869-27-septembre-2011-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1255529/xience-v-3857-xience-prime-3859-27-septembre-2011-synthese-d-avis
2011
false
France
French
health technology assessment
guidelines for medical devices use
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1297487/taxus-element-29-novembre-2011-3996-synthese-d-avis
2011
France
French
ACTIVE CORONARY STENT
treatment outcome
coronary artery disease
paclitaxel
tubulin modulators
Drug-Eluting stents
health technology assessment
guidelines for medical devices use

---
http://www.has-sante.fr/portail/jcms/c_1033010/xience-v-22-mars-2011-3398-avis
http://www.has-sante.fr/portail/jcms/c_1035155/xience-v-23-mars-2011-3398-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1033013/xience-prime-22-mars-2011-3399-avis
http://www.has-sante.fr/portail/jcms/c_1035150/xience-prime-23-mars-2011-3399-avis
2011
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1045974/xience-v-22-mars-2011-3398-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1053203/xience-v-3398-xience-prime-3399-22-mars-2011-synthese-d-avis
2011
false
France
French
ACTIVE CORONARY STENT
health technology assessment
guidelines for medical devices use
Everolimus
Drug-Eluting stents
coronary artery disease
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_996539/zilver-ptx-09-novembre-2010-2807-avis
http://www.has-sante.fr/portail/jcms/c_1096190/zilver-09-novembre-2010-2807-avis
2010
France
French
PERIPHERAL STENT, OTHER
ACTIVE CORONARY STENT
health technology assessment
Drug-Eluting stents
lower extremity
paclitaxel
arterial occlusive diseases
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_940810/promus-element-long-cnedimts-du-23-mars-2010-2504
http://www.has-sante.fr/portail/jcms/c_941548/promus-element-long-cnedimts-du-23-mars-2010-2504
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
immunosuppressive agents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_950926/endeavor-04-mai-2010-2373-avis
http://www.has-sante.fr/portail/jcms/c_950927/endeavor-04-mai-2010-2373-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
immunosuppressive agents
zotarolimus
sirolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_950917/endeavor-sprint-rx-04-mai-2010-2377-avis
http://www.has-sante.fr/portail/jcms/c_950919/endeavor-sprint-04-mai-2010-2377-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
immunosuppressive agents
sirolimus
zotarolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_973405/xience-v-29-juin-2010-2533-avis
http://www.has-sante.fr/portail/jcms/c_973400/xience-v-29-juin-2010-2533-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1001613/endeavor-et-endeavor-sprint-rx-04-mai-2010-2373-2377-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1016552/endeavor-endeavor-sprint-04-mai-2010-2373-2377-synthese-d-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
zotarolimus
sirolimus
sirolimus
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_980895/taxus-element-14-septembre-2010-2721-avis
http://www.has-sante.fr/portail/jcms/c_984143/taxus-element-14-septembre-2010-2721-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
blood vessel prosthesis
coronary disease
paclitaxel

---
http://www.has-sante.fr/portail/jcms/c_991919/promus-12-octobre-2010-3009-avis
http://www.has-sante.fr/portail/jcms/c_991921/promus-12-octobre-2010-3009-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
blood vessel prosthesis
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_994680/endeavor-resolute-12-octobre-2010-2806-avis
http://www.has-sante.fr/portail/jcms/c_994684/endeavor-resolute-12-octobre-2010-2806-avis
2010
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
zotarolimus
sirolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1011979/resolute-integrity-21-decembre-2010-3352-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
zotarolimus
sirolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1001631/xience-v-et-xience-prime-29-juin-2010-2532-2533-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1016556/xience-v-xience-prime-29-juin-2010-2532-2533-synthese-d-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_973407/xience-prime-29-juin-2010-2532-avis
http://www.has-sante.fr/portail/jcms/c_973409/xience-prime-29-juin-2010-2532-avis
2010
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_773453/taxus-liberte
http://www.has-sante.fr/portail/jcms/c_779546/cepp-1949-taxus-liberte
2009
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
blood vessel prosthesis
paclitaxel
coronary artery disease
health technology assessment
treatment outcome

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F07D
2009
Belgium
French
Dutch
CORONARY STENT, OTHER
Drug-Eluting stents
coronary restenosis
treatment outcome
risk factors
acute coronary syndrome
journal article

---
https://medicalforum.ch/fr/detail/doi/fms.2009.06910/
2009
false
Switzerland
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary restenosis
risk assessment
Drug-Eluting stents
journal article
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_938820/genous-bio-engineered-r-stent-endoprothese-1891-cnedimts-du-22-decembre-2009
http://www.has-sante.fr/portail/jcms/c_938834/genous-bio-engineered-r-stent-endoprothese-1891-cnedimts-du-22-decembre-2009
2009
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
antigens, CD34
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_867966/evaluation-des-endoprotheses-coronaires-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_868702/evaluation-des-endoprotheses-coronaires-a-liberation-de-principe-actif
http://www.has-sante.fr/portail/jcms/c_868709/annexes-du-rapport-d-evaluation-des-endoprotheses-a-liberation-de-principe-actif
2009
true
France
French
ACTIVE CORONARY STENT
Contraindications, Procedure
Drug-Eluting stents
blood vessel prosthesis
coronary artery disease
insurance, health, reimbursement
angioplasty, balloon, coronary
hospitalization
reoperation
stents
treatment outcome
Cost-Benefit analysis
Drug-Eluting stents
Drug-Eluting stents
Drug-Eluting stents
health technology assessment
economic evaluation
comparative study

---
http://www.has-sante.fr/portail/jcms/c_892686/promus-element-cnedimts-du-08-decembre-2009-2311
http://www.has-sante.fr/portail/jcms/c_892968/promus-element-cnedimts-du-08-decembre-2009-2311
2009
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
immunosuppressive agents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_892971/xience-prime-cnedimts-du-08-decembre-2009-2310
http://www.has-sante.fr/portail/jcms/c_892972/xience-prime-cnedimts-du-08-decembre-2009-2310
2009
false
France
French
ACTIVE CORONARY STENT
Everolimus
immunosuppressive agents
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_864993/xience-prime-cnedimts-du-22-septembre-2009-2246
http://www.has-sante.fr/portail/jcms/c_864995/xience-prime-cnedimts-du-22-septembre-2009-2246
2009
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
blood vessel prosthesis
coronary artery disease
immunosuppressive agents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_643789
http://www.has-sante.fr/portail/display.jsp?id=c_643795
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
paclitaxel
heart failure
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_658716
http://www.has-sante.fr/portail/display.jsp?id=c_658718
2008
France
French
ACTIVE CORONARY STENT
coronary artery disease
sirolimus
Drug-Eluting stents
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_658717
http://www.has-sante.fr/portail/display.jsp?id=c_658721
2008
false
France
French
ACTIVE CORONARY STENT
Everolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_659705
http://www.has-sante.fr/portail/display.jsp?id=c_659735
2008
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_666117
http://www.has-sante.fr/portail/jcms/c_670970/cepp-1783
2008
France
French
ACTIVE CORONARY STENT
prostatic neoplasms
brachytherapy
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_666118/cypher-select
http://www.has-sante.fr/portail/jcms/c_670992/cepp-1747
2008
France
French
ACTIVE CORONARY STENT
sirolimus
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_667032/helistent-titan-2
http://www.has-sante.fr/portail/jcms/c_670950/cepp-1633
2008
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
titanium
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_666117/cypher-select-plus
http://www.has-sante.fr/portail/jcms/c_670970/cepp-1783
2008
France
French
ACTIVE CORONARY STENT
coronary artery disease
sirolimus
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_671429/endeavor
http://www.has-sante.fr/portail/jcms/c_671462/cepp-1744
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
angioplasty, balloon, coronary
coronary restenosis
zotarolimus
health technology assessment
treatment outcome

---
https://medicalforum.ch/fr/detail/doi/fms.2008.06378/
2008
false
Switzerland
French
Drug-Eluting stents
Drug-Eluting stents
journal article
image

---
http://www.has-sante.fr/portail/jcms/c_703389/nobori
http://www.has-sante.fr/portail/jcms/c_703391/nobori-cepp-1784
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
sirolimus
umirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_716885/endeavor
http://www.has-sante.fr/portail/jcms/c_716886/endeavor-cepp-1879
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
coronary artery disease
zotarolimus
health technology assessment
treatment outcome

---
https://rmlg.uliege.be/article/1786
2008
Belgium
French
Drug-Eluting stents
risk assessment
cardiovascular diseases
journal article

---
http://www.has-sante.fr/portail/jcms/c_731812/cypher-select-plus
http://www.has-sante.fr/portail/jcms/c_731821/cypher-select-plus-cepp-1865
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_731501/pro-kinetic-energy
http://www.has-sante.fr/portail/jcms/c_731503/pro-kinetic-energy-cepp-1930
2008
France
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary artery disease
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_725165/taxus-liberte
http://www.has-sante.fr/portail/jcms/c_725166/taxus-liberte-cepp-1858
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
paclitaxel
health technology assessment
treatment outcome

---
https://rmlg.uliege.be/article/1816
2008
Belgium
French
CORONARY STENT, OTHER
Drug-Eluting stents
diabetes mellitus
coronary artery disease
risk factors
risk assessment
diabetes complications
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_517989
2007
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_572582
2007
false
France
French
ACTIVE CORONARY STENT
Everolimus
immunosuppressive agents
diabetes mellitus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_522790
2007
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_603236
http://www.has-sante.fr/portail/display.jsp?id=c_603238
2007
France
French
ACTIVE CORONARY STENT
coronary artery disease
paclitaxel
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_572610
2007
false
France
French
ACTIVE CORONARY STENT
Everolimus
diabetes mellitus
Drug-Eluting stents
coronary stenosis
immunosuppressive agents
health technology assessment
treatment outcome

---
http://kce.fgov.be/fr/publication/report/drug-eluting-stents-en-belgique-health-technology-assessment
2006
Belgium
French
English
CORONARY STENT, OTHER
Drug-Eluting stents
belgium
costs and cost analysis
coronary stenosis
Drug-Eluting stents
economic evaluation
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455477
2006
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455231
2006
France
French
CORONARY STENT, OTHER
carbon
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455185
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_455178
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398798
2006
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398797
2006
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398739
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
zotarolimus
health technology assessment
treatment outcome

---
https://www.cadth.ca/fr/evaluation-economique-des-stents-elution-medicamenteuse-0
https://www.cadth.ca/sites/default/files/pdf/272_drug_eluting_stents_to_f.pdf
2005
true
Canada
French
Drug-Eluting stents
health technology assessment
economic evaluation
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_398722
2005
France
French
ACTIVE CORONARY STENT
tubulin modulators
antineoplastic agents, phytogenic
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398630
2005
France
French
CORONARY STENT, OTHER
prostheses and implants
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398629
2005
France
French
CORONARY STENT, OTHER
prostheses and implants
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398627
2005
France
French
CORONARY STENT, OTHER
trace elements
silicon
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
https://www.cadth.ca/fr/evaluation-economique-des-inhibiteurs-des-recepteurs-la-glycoproteine-iib-iiia-en-prevision-dune
https://www.cadth.ca/sites/default/files/pdf/203_glycoproteins_tr_f.pdf
2005
true
Canada
French
CORONARY STENT, OTHER
economic evaluation
health technology assessment
arterial occlusive diseases
Drug-Eluting stents
angioplasty, balloon, coronary
drug evaluation
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398584
2004
France
French
CORONARY STENT, OTHER
anti-bacterial agents
antifungal agents
immunosuppressive agents
antibiotics, antineoplastic
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398556
2004
France
French
CORONARY STENT, OTHER
coronary stenosis
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/analyse-economique-des-stents-coronariens-a-elution-medicamenteuse-une-perspective-quebecoise.html
2004
false
Canada
French
CORONARY STENT, OTHER
quebec
Drug-Eluting stents
coronary restenosis
Cost-Benefit analysis
treatment outcome
myocardial revascularization
technology assessment, biomedical
australia
france
united states
spain
myocardial revascularization
coronary restenosis
models, economic
sensitivity and specificity
risk factors
risk
Drug-Eluting stents
patient selection
patient selection
bibliography of medicine
Drug-Eluting stents
economic evaluation
table
figure
health technology assessment

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/mtc/e-docs/00/04/01/C3/resume.md?type=text.html
http://www.john-libbey-eurotext.fr/fr/revues/medecine/mtc/e-docs/00/04/01/C3/article.md?type=text.html
2004
France
French
journal article
CORONARY STENT, OTHER
Drug-Eluting stents
drug delivery systems
sirolimus
angioplasty, balloon, coronary
coronary stenosis
paclitaxel
treatment outcome

---
http://www.cadth.ca/media/pdf/152_No23_absorbablestents_f.pdf
2004
Canada
French
CORONARY STENT, OTHER
Drug-Eluting stents
coronary disease
blood vessel prosthesis
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398474
2003
France
French
CORONARY STENT, OTHER
angioplasty, balloon, coronary
diabetes mellitus
Drug-Eluting stents
coronary stenosis
paclitaxel
health technology assessment
treatment outcome

---
https://www.cadth.ca/sites/default/files/pdf/212_drugelutingstents_cetap_f.pdf
2002
Canada
French
CORONARY STENT, OTHER
blood vessel prosthesis
coronary restenosis
Drug-Eluting stents
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398455
2002
France
French
CORONARY STENT, OTHER
coronary restenosis
angioplasty, balloon, coronary
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
health technology assessment
treatment outcome

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.